Patrick Frost, PhD

Patrick Frost, PhD

Feb 02, 2016

Group 6 Copy 49
-2
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

A Bird's-eye View of Frog Habitats: Using a Drone to Survey Wetlands

I study vulnerable frog species that inhabit human-constructed wetlands in the Grand River Grasslands of...

CRISPR Capsules: Packaging Cas9 with bacterial outer membrane vesicles

NU iGEM is creating a delivery system for an innovative antibiotic method centered around CRISPR, a powerful...

Cataloging Insect and Bat Diversity in Belize

This project intends to create a major entomology collection housed in Belize and to conduct bat inventories...

Backer Badge Funded